Search
Returning search results with filters:
Remove filter for
Audience: Healthcare
Remove filter for
Category: Drugs
Remove filter for
Type: Recall
Clear all
Type
Audience
Category
Issue
Last updated
Recall class
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 15 of 392 items.
Affected lots may contain the presence of foreign matter.
RecallHealth product recall | 2023-01-31
Presence of particulate matter in affected lot.
RecallHealth product recall | 2023-01-18
Product sterility may be compromised in the affected lot.
RecallHealth product recall | 2022-12-14
The colour is out of specification in the affected lot(s).
RecallHealth product recall | 2022-12-06
Affected lot being voluntarily recalled due to a series of adverse reactions.
RecallHealth product recall | 2022-12-01
Affected lot is labelled with the incorrect strength and ingredient
RecallHealth product recall | 2022-10-24
Potential for a future out of specification result during shelf-life
RecallHealth product recall | 2022-09-28
Product sold without market authorization (DIN) in Canada. All affected lots may contain bimatoprost, a prostaglandin analogue, which is listed on the prescription drug list. Test results for Lot 20220331 found the product to contain bimatoprost.…
RecallHealth product recall | 2022-09-26
Out of specification result for assay test in the affected lots
RecallHealth product recall | 2022-08-31
Affected lot may contain particulate matter
RecallHealth product recall | 2022-08-30
Jamp Pharma Corporation is recalling one lot (D10776B) of Jamp-Atorvastatin Calcium after one bottle labelled to contain 10 mg tablets of Jamp-Atorvastatin Calcium was found to contain 40 mg tablets of Jamp-Atorvastatin Calcium.
Pharmacists may not…
RecallHealth product recall | 2022-08-29
Pharmascience Inc. is recalling one lot of pms-Hydromorphone, 2 mg tablets, (lot 639268) as the bottles may contain hydromorphone tablets of a different strength (8 mg), meaning they contain higher amounts of hydromorphone. Products from the affected lot…
RecallHealth product recall | 2022-08-22
The dissolution for vitamin D3 is out of specification in the affected lots.
RecallHealth product recall | 2022-08-22
Taro Pharmaceuticals Inc. is recalling all lots of Taro-Zoledronic acid injection 5mg/100mL (DIN 02415100) because they may contain particulate matter.
Zoledronic acid is a prescription drug used to treat and prevent osteoporosis and to treat Paget's…
RecallHealth product recall | 2022-08-10
Jamp Pharma Corporation is recalling one lot (MHC1403A) of Jamp-Atorvastatin 40 mg tablets due to possible contamination with latex pieces during manufacturing. A piece of latex was found in one tablet from the affected lot.…
RecallHealth product recall | 2022-08-08